Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study.
Journal: Pediatric blood & cancer
Published: December 16, 2025
A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.
Journal: Cell reports. Medicine
Published: July 31, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence.
Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.
Journal: Nature communications
Published: February 21, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.
Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence.
Journal: Cancer cell
Published: February 17, 2025
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 04, 2024
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.
Journal: Neuro-oncology
Published: July 31, 2024
A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.
Journal: bioRxiv : the preprint server for biology
Published: March 18, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Journal: The Lancet. Oncology
Published: August 28, 2023
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Journal: Journal of the National Cancer Institute
Published: March 09, 2023
Last Updated: 09/26/2026